January 7, 2021
The Federal Circuit’s Ball Metal Decision Raises Important Considerations for Pharma and Biologics Patents
April 3, 2020
D.C. Circuit Concludes that Serial Periods of Exclusivity May Be Available Under the Orphan Drug Act
February 1, 2020
Federal Circuit Continues Trend of Finding Diagnostic Inventions to Be Patent-Ineligible
August 20, 2019
Fed. Circ.'s Arduous Legal Landscape For Diagnostic Patents
August 13, 2019
Federal Circuit Continues Trend of Finding Diagnostic Inventions to Be Patent-Ineligible
April 29, 2019
Big Pharma Should Watch SCOTUS After Circuit Court Finds New Drug Uses Patentable
January 17, 2019
Takeaways From Fed. Circ. Hatch-Waxman IPR Case